蓝丰生化：2025年第一次临时股东会决议公告

Group 1 - The core point of the article is that Lanfeng Biochemical announced the approval of several proposals at its first extraordinary general meeting of shareholders in 2025, including adjustments to the performance assessment indicators for the 2024 restricted stock incentive plan [2] Group 2 - The company held its first extraordinary general meeting of shareholders in 2025 on August 15 [2] - The meeting reviewed and approved the proposal regarding the adjustment of performance assessment indicators for the 2024 restricted stock incentive plan [2] - Multiple proposals were discussed and approved during the meeting [2]